skip to Main Content

Researchers Develop New Blood Test to Detect Early Stage Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Due to diffuse symptoms, pancreatic cancer is usually diagnosed very late in the disease progression. Therefore, despite pancreatic cancer representing less than 3% of all cancer cases, more people currently die from it than breast cancer. By 2030, pancreatic cancer is expected to be the second deadliest type of cancer in the world.

“Our test can detect pancreatic cancer with 96% accuracy at stage I and II, while there is still the possibility of successful surgical intervention.  Read more . . . 

Back To Top